Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc.

ATXI
Avenue Therapeutics, Inc.US flagOther OTC
0.26
USD
-0.13
- -
856,691.00Market Cap

Avenue Therapeutics, Inc. (ATXI) Stock Split History

Learn about Avenue Therapeutics, Inc.'s most recent 1-for-75 basis stock split on April 26, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Avenue Therapeutics, Inc.'s most recent stock split

Split Date: 2024-04-26
Split Ratio: 1:75
Price Before Split: $0.08
Price After Split: $0.00

Developer API

Get ATXI split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ATXI

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 75.00 times fewer shares (a 1:75 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Avenue Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-04-261:75Yes$0.08$0.00
2022-09-231:15Yes$0.30$0.02

About Avenue Therapeutics, Inc.

Company overview and industry information

Avenue Therapeutics, Inc. (ATXI) operates in the Biotechnology industry. The recent 1-for-75 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Avenue Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.